News
Teva Pharmaceuticals agreed Thursday to pay $523 million to New York to settle claims stemming from the company’s role in the opioids crisis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results